Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

penetrance

(PEH-neh-trunts)
Describes how likely it is that a person who has a certain disease-causing mutation (change) in a gene will show signs and symptoms of the disease. Not everyone who has the mutation will develop the disease. For example, some people who have a BRCA1 or BRCA2 gene mutation will develop cancer during their lifetime, but others will not. Currently, there is no way to know which people who have a cancer-causing mutation will develop cancer. Complete penetrance means that every person who has the mutation will show signs and symptoms of the disease.
Search NCI's Dictionary of Cancer Terms